#152706

A2780 Cell Line

Cat. #152706

A2780 Cell Line

Cat. #: 152706

Unit size: 1x10^6 cells / vial

Organism: Human

Tissue: Ovary

Disease: Cancer

Model: Tumour line

£800.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: National Cancer Institute

Tool Details
Applications
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: A2780 Cell Line
  • Alternate name: A-2780 Cells; A2780 ovarian cancer cell line
  • Cancer: Gynaecologic cancer
  • Cancers detailed: Ovarian
  • Research fields: Cancer;Drug development
  • Organism: Human
  • Tissue: Ovary
  • Disease: Cancer
  • Growth properties: Adherent
  • Model: Tumour line
  • Conditional: Yes
  • Application: A2780 cell line is used in toxicity testing and cancer genetic studies.
  • Production details: Split sub-confluent cultures (70-80%) 1:3 to 1:6 i.e. seeding at 3-6x10,000cells/cm2 using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37°C.
  • Additional notes: STR-PCR Data: Amelogenin: X CSF1PO: 10,11 D13S317: 12,13 D16S539: 11,13 D5S818: 11,12 D7S820: 10 THO1: 6 TPOX: 8,10 vWA: 15,16
  • Cellosaurus id: CVCL_0134

Applications

  • Application: A2780 cell line is used in toxicity testing and cancer genetic studies.
  • Application notes: Points of Interest STR-PCR Data: Amelogenin: X CSF1PO: 10,11 D13S317: 12,13 D16S539: 11,13 D5S818: 11,12 D7S820: 10 THO1: 6 TPOX: 8,10 vWA: 15,16 Concentration Vial has between 1-5 million cells as standard, however this may vary.

Handling

  • Format: Frozen
  • Growth medium: RPMI 1640 + 2mM Glutamine + 10% Foetal Bovine Serum (FBS).
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

Related Tools

  • Related tools: A2780ADR Cell Line ; A2780cis Cell Line

References

  • Nusinow et al. 2020. Cell. 180(2):387-402.e16. PMID: 31978347.
  • Ghandi et al. 2019. Nature. 569(7757):503-508. PMID: 31068700.
  • Dutil et al. 2019. Cancer Res. 79(7):1263-1273. PMID: 30894373.
  • Zhao et al. 2017. Clin Proteomics. 14:20. PMID: 28546799.
  • Medrano et al. 2017. Cell Rep. 18(10):2343-2358. PMID: 28273451.
  • Pfankuchen et al. 2015. Biochem Pharmacol. 97(2):147-57. PMID: 26239805.
  • Abdulkhalek et al. 2014. Clin Transl Med. 3(1):28. PMID: 26932374.
  • Januchowski et al. 2014. Biomed Res Int. 2014:365867. PMID: 24804215
  • Parker et al. 1991. J Clin Invest. 87(3):772-777. PMID: 1999494.